It is noteworthy that both the global loss of 5hmC and the gain of promoter-specific hypermethylation observed here are hallmarks of many cancers, and loss of a TET-mediated demethylase activity through mutation or substrate inhibition is being implicated in a growing number of malignancies [31]. Here, MBD2 is linked to cancer.